SECAUCUS, N.J., Nov. 20, 2019 /PRNewswire/ — Quest Diagnostics (NYSE: DGX), the world’s leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.53 per share, payable on January 29, 2020 to shareholders of record of Quest Diagnostics common stock on January 14, 2020.
About Quest Diagnostics
Quest Diagnostics empowers people to take action to improve health outcomes. Derived from the world’s largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve health care management. Quest annually serves one in three adult Americans and half the physicians and hospitals in the United States, and our 46,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives. www.QuestDiagnostics.com.
View original content to download multimedia:http://www.prnewswire.com/news-releases/quest-diagnostics-declares-quarterly-cash-dividend-300961551.html
SOURCE Quest Diagnostics
Calgary, Alberta--(Newsfile Corp. - February 3, 2026) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE:…
Juno Health Rated Highest Overall in Key "Future-Ready" Measures for Small and Rural Hospitals; RHT…
NAPLES, FL / ACCESS Newswire / February 3, 2026 / Stemtech Corporation, the global leader…
Clinical progress, pipeline expansion, and operational momentum underpin leadership continuity as the Company advances into…
ESTERO, FL / ACCESS Newswire / February 3, 2026 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP)…
Company to Participate in BIO Partnering Summit and Present Phase 1 Ketamir-2 Data at American…